Mary L. Huggins

Mutant forms of tumour necrosis factor receptor I that occur in TNF‐receptor‐associated periodic syndrome retain signalling functions but show abnormal behaviour

Ian Todd, Paul Radford, Kelly‐Ann Draper‐Morgan et al. · Immunology · 2004 · 94 citations · Full text

Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor–associated periodic syndrome: Differences between cell types

Mary L. Huggins, Paul Radford, Richard S. McIntosh et al. · Arthritis & Rheumatism · 2004 · 77 citations

Protection provided by a commercially available vaccine against different strains of turkey rhinotracheitis virus

J. Cook, Mary L. Huggins, Michael S. Woods et al. · Veterinary Record · 1995 · 54 citations

Vaccination, Vaccine Safety, Vaccine Development +8

Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells

M R Amel Kashipaz, Mary L. Huggins, Peter Lanyon et al. · Lupus · 2003 · 53 citations

APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics

Athanassios Iliadis, Allan C. Brown, Mary L. Huggins · Computer Methods and Programs in Biomedicine · 1992 · 44 citations

Dosage Regimen Calculations, Pharmacokinetic Modeling, Medicine +7